AMS 2021 Specialty Drug Report
7.07.22
Chargemaster Confusion
The Hospital Price Transparency Paradox
AMS 2020 Specialty Drug Trend Report
6.21.2021
AMS 2019 Specialty Drug Trend Report
Our 2019 Drug Report reveals payers lack of critical payment intelligence
AMS 2018 Specialty Drug Trend Report
Specialty drugs continue to skyrocket by FDA approvals as well as price
The Debris of Failure
By establishing the right foundational approach coupled with the right platform, organizations can drive transformation. An Article by AMS CEO Peter Borans.
Spinal Cord White Paper
The Rising Utilization and Costs of Spinal Cord Stimulators
The Big Screw Article
How Manufacturers, Insurers, Providers, PBMs, and the Government Are Keeping Us in the Dark
Auto-Adjudication Article
$200M; $18 PE/PM: Why You Should Rethink Your Auto-Adjudication Strategy
Insys Update
Falsifying medical records and misleading insurance companies helped contribute to the deadly opioid crisis
Liquid Biopsies Article
Biotherapeutics have been dominating healthcare headlines recently with good reason